Echosens And Novo Nordisk Announce Partnership To Increase Awareness And Advance Early Diagnosis Of Nash
Echosens, A High-Technology Company Offering Liver Diagnostic Solutions, And Novo Nordisk A/S, A Leading Global Healthcare Company, Today Announced A Partnership To Advance Early Diagnosis Of Non-Alcoholic Steatohepatitis (Nash) And Increase Awareness Of The Disease Among Patients, Healthcare Providers And Other Stakeholders.Nash Is A Chronic Metabolic Liver Disease That Affects More Than 115 Million People Worldwide1. The Condition Is Caused By Build-Up Of Fat And Inflammation In The Liver. This Causes Progressive Damage To The Liver And Can Lead To End-Stage Liver Disease And Death.Nash Is A
Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!
